India's Biocon Ltd hopes to acquire a company by the end of the 2007/08 fiscal year next March to boost its business in overseas markets, Chairman Kiran Mazumdar-Shaw said on Monday.

We are looking at U.S., Europe and some of the emerging markets, she told reporters at a World Economic Forum summit in New Delhi, referring to locations of possible acquisitions.

She said the company had six pharmaceutical products in its discovery pipeline, and that Biocon planned to launch insulin in Europe in the next 18 to 24 months. (Reporting by Sumeet Chatterjee; Editing by John Mair)